Ambea AB (publ) (LON:0RNX)
118.30
-14.85 (-11.15%)
Feb 12, 2026, 4:21 PM GMT
Ambea AB Revenue
In the year 2025, Ambea AB had annual revenue of 16.21B SEK with 13.20% growth. Ambea AB had revenue of 4.36B in the quarter ending December 31, 2025, with 16.00% growth.
Revenue
16.21B SEK
Revenue Growth
+13.20%
P/S Ratio
0.60
Revenue / Employee
426.58K SEK
Employees
38,000
Market Cap
787.32M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.21B | 1.89B | 13.20% |
| Dec 31, 2024 | 14.32B | 751.00M | 5.53% |
| Dec 31, 2023 | 13.57B | 934.00M | 7.39% |
| Dec 31, 2022 | 12.64B | 1.16B | 10.08% |
| Dec 31, 2021 | 11.48B | 395.00M | 3.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Spire Healthcare Group | 1.55B |
| CVS Group | 673.20M |
| HUTCHMED (China) | 439.54M |
| Oxford Nanopore Technologies | 204.69M |